G. Ekin Atilla-Gokcumen

G. Ekin Atilla-Gokcumen


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
EMEryn K. Matich
Eryn K. Matich
NSNita G. Chavez Soria
Nita G. Chavez Soria
DADiana S. Aga
Diana S. Aga
GAG. Ekin Atilla-Gokcumen
G. Ekin Atilla-Gokcumen

19 January 2017 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
DLDarleny Y. Lizardo
Darleny Y. Lizardo
YLYen-Lung Lin
Yen-Lung Lin
OGOmer Gokcumen
Omer Gokcumen
GAG. Ekin Atilla-Gokcumen
G. Ekin Atilla-Gokcumen
Cellular replicative senescence, a state of permanent cell-cycle arrest, has been linked to organismal aging, tissue repair and tumorigenesis. In this study, we comparatively investigated the global lipid profiles and mRNA content of proliferating and senescent-state BJ fibroblasts. We found that both expression levels of lipid-regulating genes and the abundance of specific lipid families, are actively regulated. We further found that 19 specific polyunsaturated triacylglycerol species constituted the most prominent changes in lipid composition during replicative senescence. Based on the transcriptome analysis, we propose that the activation of CD36-mediated fatty acid uptake and diversion to glycerolipid biosynthesis could be responsible for the accumulation of triacylglycerols during replicative senescence. This, in turn, could be a cellular mechanism to prevent lipotoxicity under increased oxidative stress conditions observed in this process. Our results indicate that regulation of specific lipid species has a central role during replicative senescence.

1 December 2017 in Cell Chemical Biology
Verified
Journal Article
Closed access
LPLaura R. Parisi
Laura R. Parisi
NLNasi Li
Nasi Li
GAG. Ekin Atilla-Gokcumen
G. Ekin Atilla-Gokcumen

11 September 2024 in Environmental Science & Technology
Verified
Journal Article
Open access
KRKarla M. Ríos-Bonilla
Karla M. Ríos-Bonilla
DADiana S. Aga
Diana S. Aga
JLJungeun Lee
Jungeun Lee
MKMaria König
Maria König
WQWeiping Qin
Weiping Qin
BEBeate Isabella Escher
Beate Isabella Escher
Per- and polyfluoroalkyl substances (PFAS) may cause various deleterious health effects. Epidemiological studies have demonstrated associations between PFAS exposure and adverse neurodevelopmental outcomes. The cytotoxicity, neurotoxicity, and mitochondrial toxicity of up to 12 PFAS including perfluoroalkyl carboxylates, perfluoroalkyl sulfonates, 6:2 fluorotelomer sulfonic acid (6:2 FTSA), and hexafluoropropylene oxide-dimer acid (HPFO-DA) were tested at concentrations typically observed in the environment (e.g., wastewater, biosolids) and in human blood using high-throughput in vitro assays. The cytotoxicity of all individual PFAS was classified as baseline toxicity, for which prediction models based on partition constants of PFAS between biomembrane lipids and water exist. No inhibition of the mitochondrial membrane potential and activation of oxidative stress response were observed below the cytotoxic concentrations of any PFAS tested. All mixture components and the designed mixtures inhibited the neurite outgrowth in differentiated neuronal cells derived from the SH-SY5Y cell line at concentrations around or below cytotoxicity. All designed mixtures acted according to concentration addition at low effect and concentration levels for cytotoxicity and neurotoxicity. The mixture effects were predictable from the experimental single compounds' concentration-response curves. These findings have important implications for the mixture risk assessment of PFAS.

13 December 2017 in Biochemistry
Verified
Journal Article
Closed access
NLNasi Li
Nasi Li
YSYasemin Sancak
Yasemin Sancak
JFJonna Frasor
Jonna Frasor
GAG. Ekin Atilla-Gokcumen
G. Ekin Atilla-Gokcumen

24 August 2018 in Oncogenesis
Verified
Journal Article
Open access
PDF file
VBViktor Brovkovych
Viktor Brovkovych
YIYasir Izhar
Yasir Izhar
JDJeanne M. Danes
Jeanne M. Danes
ODOleskii Dubrovskyi
Oleskii Dubrovskyi
ISIsin T. Sakallioglu
Isin T. Sakallioglu
JFJonna Frasor
Jonna Frasor
Given the dependence of cancers on de novo lipogenesis, we tested the effect of fatostatin, a small molecule thought to target this pathway by blocking activation of SREBP transcription factors, in breast cancer cell lines and xenograft tumors. We found that estrogen receptor (ER) positive cells were more sensitive to fatostatin than ER negative cells and responded with cell cycle arrest and apoptosis. Surprisingly, we found that rather than inhibiting lipogenesis, fatostatin caused an accumulation of lipids as a response to endoplasmic reticulum stress rather than inhibition of SREBP activity. In particular, ceramide and dihydroceramide levels increased and contributed to the apoptotic effects of fatostatin. In addition, an accumulation of triacylglycerides (TAGs), particularly those containing polyunsaturated fatty acids (PUFAs), was also observed as a result of elevated diacylglycerol transferase activity. Blocking PUFA-TAG production enhanced the apoptotic effect of fatostatin, suggesting that these lipids play a protective role and limit fatostatin response. Together, these findings indicate that the ability of breast cancer cells to respond to fatostatin depends on induction of endoplasmic reticulum stress and subsequent ceramide accumulation, and that limiting production of PUFA-TAGs may be therapeutically beneficial in specific tumor subtypes.